✦ LIBER ✦
Rationale and design of a placebo-controlled trial to evaluate the steroid-sparing effects of anti-IL5 monoclonal antibody (mepolizumab): Focus on cutaneous outcomes in patients with hypereosinophilic syndrome (HES)
- Book ID
- 116582428
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 56 KB
- Volume
- 56
- Category
- Article
- ISSN
- 1097-6787
No coin nor oath required. For personal study only.